These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 19351532)
1. Trypanosoma cruzi: altered parasites after in vitro treatment with gangliosides, a therapeutic agent in experimental Chagas' disease. Cossy Isasi S; Rodríguez M; Pereira BM; Díaz-Luján C; Fretes RE; Haüen DI Exp Parasitol; 2009 Jul; 122(3):218-25. PubMed ID: 19351532 [TBL] [Abstract][Full Text] [Related]
2. Ultrastructural alterations and growth inhibition of Trypanosoma cruzi and Leishmania major induced by Bothrops jararaca venom. Gonçalves AR; Soares MJ; de Souza W; DaMatta RA; Alves EW Parasitol Res; 2002 Jul; 88(7):598-602. PubMed ID: 12107450 [TBL] [Abstract][Full Text] [Related]
3. Novel strategy in Trypanosoma cruzi cell invasion: implication of cholesterol and host cell microdomains. Fernandes MC; Cortez M; Geraldo Yoneyama KA; Straus AH; Yoshida N; Mortara RA Int J Parasitol; 2007 Nov; 37(13):1431-41. PubMed ID: 17582418 [TBL] [Abstract][Full Text] [Related]
4. Effect of L-leucine methyl ester on growth and ultrastructure of Trypanosoma cruzi. Adade CM; Figueiredo RC; De Castro SL; Soares MJ Acta Trop; 2007 Jan; 101(1):69-79. PubMed ID: 17250794 [TBL] [Abstract][Full Text] [Related]
5. Trypanocidal action of 2,4-dichloro-6-phenylphenoxyethyl diethylamine hydrobromide (Lilly 18947) on Trypanosoma cruzi. Bernacchi AS; Franke De Cazzulo B; Castro JA Acta Pharmacol Sin; 2002 May; 23(5):399-404. PubMed ID: 11978189 [TBL] [Abstract][Full Text] [Related]
6. Different cell death pathways induced by drugs in Trypanosoma cruzi: an ultrastructural study. Menna-Barreto RF; Salomão K; Dantas AP; Santa-Rita RM; Soares MJ; Barbosa HS; de Castro SL Micron; 2009 Feb; 40(2):157-68. PubMed ID: 18849169 [TBL] [Abstract][Full Text] [Related]
7. Biological, ultrastructural effect and subcellular localization of aromatic diamidines in Trypanosoma cruzi. Batista DG; Pacheco MG; Kumar A; Branowska D; Ismail MA; Hu L; Boykin DW; Soeiro MN Parasitology; 2010 Feb; 137(2):251-9. PubMed ID: 19765349 [TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi cell invasion and traffic: influence of Coxiella burnetii and pH in a comparative study between distinct infective forms. Fernandes MC; L'Abbate C; Kindro Andreoli W; Mortara RA Microb Pathog; 2007 Jul; 43(1):22-36. PubMed ID: 17448629 [TBL] [Abstract][Full Text] [Related]
9. Effect of suramin on trypomastigote forms of Trypanosoma cruzi: changes on cell motility and on the ultrastructure of the flagellum-cell body attachment region. Bisaggio DF; Campanati L; Pinto RC; Souto-Padrón T Acta Trop; 2006 May; 98(2):162-75. PubMed ID: 16716244 [TBL] [Abstract][Full Text] [Related]
10. Cell culture and animal infection with distinct Trypanosoma cruzi strains expressing red and green fluorescent proteins. Pires SF; DaRocha WD; Freitas JM; Oliveira LA; Kitten GT; Machado CR; Pena SD; Chiari E; Macedo AM; Teixeira SM Int J Parasitol; 2008 Mar; 38(3-4):289-97. PubMed ID: 17967460 [TBL] [Abstract][Full Text] [Related]
11. The effects on Trypanosoma cruzi of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction. Menna-Barreto RF; Goncalves RL; Costa EM; Silva RS; Pinto AV; Oliveira MF; de Castro SL Free Radic Biol Med; 2009 Sep; 47(5):644-53. PubMed ID: 19501647 [TBL] [Abstract][Full Text] [Related]
12. Effect of usnic acid from the lichen Cladonia substellata on Trypanosoma cruzi in vitro: an ultrastructural study. De Carvalho EA; Andrade PP; Silva NH; Pereira EC; Figueiredo RC Micron; 2005; 36(2):155-61. PubMed ID: 15629646 [TBL] [Abstract][Full Text] [Related]
13. Biological aspects of the Trypanosoma cruzi (Dm28c clone) intermediate form, between epimastigote and trypomastigote, obtained in modified liver infusion tryptose (LIT) medium. Bourguignon SC; Mello CB; Santos DO; Gonzalez MS; Souto-Padron T Acta Trop; 2006 Apr; 98(1):103-9. PubMed ID: 16574051 [TBL] [Abstract][Full Text] [Related]
14. Trypanocidal effect of SKF525A, proadifen, on different developmental forms of Trypanosoma cruzi. Franke De Cazzulo BM; Bernacchi A; Esteva MI; Ruiz AM; Castro JA; Cazzulo JJ Medicina (B Aires); 1998; 58(4):415-8. PubMed ID: 9816705 [TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi proline racemases are involved in parasite differentiation and infectivity. Chamond N; Goytia M; Coatnoan N; Barale JC; Cosson A; Degrave WM; Minoprio P Mol Microbiol; 2005 Oct; 58(1):46-60. PubMed ID: 16164548 [TBL] [Abstract][Full Text] [Related]
16. Biological activity of 1,2,3,4-tetrahydro-beta-carboline-3-carboxamides against Trypanosoma cruzi. Valdez RH; Tonin LT; Ueda-Nakamura T; Dias Filho BP; Morgado-Diaz JA; Sarragiotto MH; Nakamura CV Acta Trop; 2009 Apr; 110(1):7-14. PubMed ID: 19063858 [TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi: productive infection is not allowed by chorionic villous explant from normal human placenta in vitro. Luján CD; Triquell MF; Sembaj A; Guerrero CE; Fretes RE Exp Parasitol; 2004; 108(3-4):176-81. PubMed ID: 15582515 [TBL] [Abstract][Full Text] [Related]
18. In vitro effects of suramin on Trypanosoma cruzi. Bisaggio DF; Adade CM; Souto-Padrón T Int J Antimicrob Agents; 2008 Mar; 31(3):282-6. PubMed ID: 18191547 [TBL] [Abstract][Full Text] [Related]
19. A novel icetexane diterpene, 5-epi-icetexone from Salvia gilliessi is active against Trypanosoma cruzi. Sanchez AM; Jimenez-Ortiz V; Sartor T; Tonn CE; García EE; Nieto M; Burgos MH; Sosa MA Acta Trop; 2006 May; 98(2):118-24. PubMed ID: 16647030 [TBL] [Abstract][Full Text] [Related]